comparemela.com


TOKYO (March 5): Takeda Pharmaceutical said it had asked regulators to approve use of Moderna's Covid-19 vaccine on Friday, which would add a third option to Japan's vaccination programme.
Japan began inoculations last month using Pfizer's vaccine, which was the first to be approved for domestic use but is imported from European factories and is in short supply.
Takeda, which is handling the Japanese approval process and imports of about 50 million Moderna doses, had earlier said approval could be given in May.
"Takeda commits to delivering Moderna's Covid-19 vaccine candidate in Japan as soon as possible," Masayuki Imagawa, the head of its Japan vaccines business unit, said in a statement.

Related Keywords

Japan ,Tokyo ,United Kingdom ,Japanese ,British ,Yoshihide Suga ,Moderna Covid ,Masayuki Imagawa ,Norihisa Tamura ,Pfizer ,Astrazeneca ,Olympics ,Takeda Pharmaceutical ,Minister Norihisa Tamura ,Minister Yoshihide Suga ,ஜப்பான் ,டோக்கியோ ,ஒன்றுபட்டது கிஂக்டம் ,ஜப்பானிய ,பிரிட்டிஷ் ,ஃபைசர் ,ஒலிம்பிக்ஸ் ,டாகேடா மருந்து ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.